NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

Point Motion, a new Winston-Salem digital health company founded by a jazz musician, is using the music of movement to detect and monitor changes in wellbeing.
Durham medical device company 410 Medical has closed on an $8 million Series A financing deal with Hatteras Venture Partners, OSF Healthcare and former investors.
The North Carolina Biotechnology Center has launched a demonstration pilot program of free genetic testing for its employees in a collaboration with health technology company Color Genomics.
Wake Forest Baptist Health and Wake Forest School of Medicine in Winston-Salem have signed a memorandum of understanding with Atrium Health to create a medical school campus in Charlotte.
For the third time since opening a Charlotte R&D and manufacturing facility in 2012, medical device company Medical Murray is celebrating the opening of an even bigger “home” in the Queen City – this one encompassing 30,000 square feet.
After more than two decades of game-changing accomplishments in the life science world, AskBio CEO Sheila Mikhail has been “discovered” as the Springboard Enterprises 2019 Northstar Honoree.
Three early stage bioscience companies in North Carolina are among 16 companies from the Southeast selected to present their funding needs to potential investors at a major industry conference next month in Florida.
Mycovia Pharmaceuticals of Durham is partnering with a major Hungarian pharmaceutical company to commercialize and manufacture one of Mycovia’s drug candidates in Europe, Latin America, Australia, Russia and other former Soviet countries.
Circassia Pharmaceuticals, a British company with U.S. headquarters in Morrisville, has commercially launched Duaklir, a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD), in the United States.
The NCBiotech Crop Commercialization Program was created to evaluate and coordinate the introduction and market development of newer high-value crops as well as improvements for existing crops that would help North Carolina farmers.
Life science professionals with an interest in gastrointestinal health of either animals or humans will want to attend the North Carolina Biotechnology Center’s Animal Health & Nutrition Forum on November 4.
Over 120 life science professionals in the race for new therapies for rare disease gathered for a full late-September day of speakers, panels, audience engagement and networking at the Rare Disease Forum at the North Carolina Biotechnology Center.
How disease foundations are carving out niches and using creative models to support drug development was the focus of the first of the two-day Invest in Cures & Rare Disease Forum, hosted at the North Carolina Biotechnology Center in late September.
Farmers in the state are moving closer to a sweet new cash crop option, thanks to a research grant from the North Carolina Tobacco Trust Fund Commission to the North Carolina Biotechnology Center.
The North Carolina Biotechnology Center awarded 18 grants and loans totaling nearly $1.4 million to bioscience companies, universities and non-profit organizations in the first quarter of its 2019-20 fiscal year.
scroll back to top of page